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Maternal fever during pregnancy 
and offspring attention deficit 
hyperactivity disorder
Kristin Gustavson1,2, Helga Ask1, Eivind Ystrom  1,2, Camilla stoltenberg1,3, W. Ian Lipkin  4,5,6,7,  
pål surén1, Siri E. Håberg9, Per Magnus1, Gun Peggy Knudsen1, Espen Eilertsen1, 
Michaeline Bresnahan4,8, Heidi Aase1, Siri Mjaaland1,2, Ezra S. susser4,8, Mady Hornig  4 & 
ted Reichborn-Kjennerud1,2
Maternal fever during pregnancy is associated with several adverse child outcomes. We investigated 
associations between maternal fever and ADHD among offspring, as well as the sub-dimensions of 
ADHD - inattention and hyperactivity/impulsivity. Data came from the Norwegian Mother and Child 
Cohort Study, including more than 114,000 children. Information about children’s ADHD diagnoses was 
obtained from the Norwegian Patient Register. Mothers reported on inattention and hyperactivity/
impulsivity symptoms in questionnaires at 8 years. Logistic regression analysis showed that children 
exposed to maternal fever in the first trimester received an ADHD diagnosis more often than unexposed 
children (Odds Ratio (OR) = 1.31, 95% confidence interval (CI) = 1.06–1.61). For children exposed 
twice or more in the first trimester, the OR was 2.64 (CI = 1.36–5.14). Linear regression analysis 
showed elevated inattention symptoms among children exposed to fever in the first (Cohen’s d = 0.09, 
CI = 0.03–0.15) and second (Cohen’s d = 0.05, CI = 0.01–0.09) trimester. Results were similar whether 
the mother had taken acetaminophen for their fever or not. Hyperactivity/impulsivity symptoms were 
not related to maternal fever. The results indicate that maternal fever in early pregnancy may be a risk 
factor for ADHD, and particularly for inattention problems. This risk is neither mitigated nor inflated by 
use of acetaminophen.
ADHD is the most common psychiatric diagnosis among children, and prenatal environmental exposures have 
been proposed as risk factors1,2. Maternal fever during pregnancy is associated with several adverse child out-
comes, such as neural tube defects, brain damage, autism spectrum disorders, lack of task persistence, and aca-
demic outcomes3–8, but the association with ADHD is uncertain.
Adverse outcomes may be due to infections that culminate in fever, or to hyperthermia itself5. Studies of 
humans and animals exposed to hyperthermia unrelated to infections (e.g. hot tubs and unusually hot weather) 
indicate that elevated temperatures may have teratogenic effects5,9,10. Cells in the central nervous system seem 
to be particularly vulnerable to hyperthermia9,11. Disturbances in brain growth and subsequent neurobehavio-
ral problems may thus occur in the offspring12. Teratogens often have different effects depending on timing13. 
In the case of fever, first-trimester exposure has been linked to brain damage and neural tube defects14, and 
second-trimester exposure to autism spectrum disorder6 and lack of task persistence3.
It is not clear whether maternal fever during pregnancy is associated with ADHD, and if timing of exposure is 
of importance. In a recent study based on a Danish birth cohort, an association was found between child ADHD 
diagnosis and maternal fever during gestational weeks 9 to 12, but not during the full pregnancy period15. We also 
lack knowledge about the degree to which maternal fever in pregnancy is equally associated with each of the two 
sub-dimensions of ADHD – inattention and hyperactivity/impulsivity. These sub-dimensions may have different 
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risk factors16–18. Hence, a better understanding of the development of ADHD requires examination of risk factors 
for the diagnosis as well as for each of the sub-dimensions.
Exposure to multiple fever episodes during pregnancy may be associated with particularly high risk of ADHD. 
Increased risk with higher number of fever episodes has been shown for autism spectrum disorders6, but this has 
not been examined for ADHD and its sub-dimensions.
Use of the antipyretic and pain reliever acetaminophen during pregnancy has been associated with adverse 
neurodevelopmental outcomes19, including ADHD20,21. An observed association between maternal fever in preg-
nancy and child ADHD could thus potentially be due to acetaminophen use for fever. It is therefore important to 
account for acetaminophen when examining the association between maternal fever and child ADHD.
The aims of the current study were to examine associations between: i) maternal fever during pregnancy and 
ADHD diagnosis in offspring, ii) maternal fever in different trimesters and child ADHD diagnosis, iii) maternal 
fever during pregnancy and maternal reports of symptoms of inattention and hyperactivity/impulsivity when 
children were 8 years old, iv) multiple fever episodes during pregnancy and child ADHD (diagnosis and symp-
toms), and v) maternal fever during pregnancy and ADHD (diagnosis and symptoms) in children of mothers who 
did versus did not take acetaminophen for their fever.
Methods
Study population. We used data from the Norwegian Mother and Child Cohort Study (MoBa)22,23. 
Participants were recruited between 1999 and 2008 from hospitals all over Norway. Women received information 
about the study, a consent form, and the first questionnaires with their postal invitation to routine ultrasound 
examination around gestational week 17. There were no exclusion criteria, but questionnaires were in Norwegian, 
so the ability to read Norwegian was a restriction22,23.
MoBa follows more than 114,000 children from almost 113,000 pregnancies (40.6% of the invited), 95,000 
mothers, and 75,000 fathers. Participants received three questionnaires during pregnancy (gestational weeks 17, 
22, and 30) and several questionnaires after the child was born (age 6 months, 18 months, 3 years, 5 years, 7 years, 
and 8 years).
The current study used data from mothers’ questionnaires in gestational weeks 17 (n = 99,947 children) and 
30 (n = 91,371), as well as 6 months (n = 85,546), 3 years (n = 56,526), and 8 years (n = 41,543) after birth. All 
available information from participants with missing data was included in analyses. This is generally recom-
mended to reduce risk of bias due to non-response24. One exception was that only women responding to all 
fever-related questionnaires were included when examining associations between fever in different trimesters and 
child ADHD (diagnosis and mother-reported symptoms). This was done to ensure that the exact same sample 
was used for all trimesters, so that we did not detect differences between trimesters that were in fact due to slightly 
different samples in the three questionnaires.
Only children from singleton births were included, in line with previous studies on prenatal risk factors for 
ADHD15,25,26. Children born in the year 2009 or later (n = 3,153) had not received the 8-year questionnaire by the 
end of the current study period in 2016, and were excluded from analyses with mother-reported symptoms at 8 
years as outcome.
For details of eligibility, see flow-chart in Fig. 1.
MoBa has a license from the Norwegian Data Inspectorate. Participants have provided written informed con-
sent. The Regional Committee for Medical Research Ethics approved MoBa and the current study. All methods 
were performed in accordance with relevant guidelines and regulations.
Exposures. Mothers reported fever episodes during pregnancy in questionnaires at gestational weeks 17 and 
30, and at 6 months after pregnancy. In week 17, women were asked if they had fever above 38.5 degrees Celsius 
(101.3 degrees Fahrenheit) during each of the following four time periods: gestational weeks 0–4, 5–8, 9–12, and 
13 or later. In week 30, women were asked if they had fever once, twice, three times, or more than three times 
from gestational week 13 onwards. For the first three fever episodes, they were asked to specify time period (i.e. 
gestational weeks 13–16, 17–20, 21–24, 25–28 and 29 or later), and the highest temperature of each episode. We 
included episodes with a temperature of 38.5 degrees Celsius or more as fever episodes, because women had only 
been asked about fever of this temperature or higher in the first questionnaire. Mothers reported fever in the last 
part of pregnancy in the questionnaire administered 6 months after delivery. They were then asked if they had 
fever in the last part of pregnancy, since completion of the previous questionnaire (yes/no). Fever episodes in 
gestational weeks 0–12 were defined as fever in first trimester, fever in weeks 13–28 as fever in second trimester, 
and in weeks 29 and after as fever in third trimester.
Number of fever episodes were counted in the first and second trimester. Fever episodes reported in two 
different questionnaires for the same period were counted only once. For each fever episode, women were asked 
what medication they had taken. Use of acetaminophen for each fever episode was coded yes/no, comprising any 
dose or duration.
Outcomes. From 2008, all government-funded in-patient and out-patient clinics in Norway report diagnoses 
to the Norwegian Patient Register (NPR). Children registered with Hyperkinetic disorder (F90) according to the 
10th revision of the International Classification of Diseases (ICD-10)27 between 2008 and 2016 were defined as 
ADHD cases in the current study.
When the children in MoBa were 8 years, mothers responded to the ADHD Rating Scale28, which includes 18 
items regarding ADHD from the Diagnostic and Statistical Manual of Diseases - 4th revision (DSM-IV)29. Nine 
items were related to hyperactivity/impulsivity, and nine to inattention. Mothers rated each statement on a scale 
from 1 (“never/rarely”) to 4 (“very often”). Examples of items were: “Fails to give close attention to details or 
makes careless mistakes in schoolwork”, “Is easily distracted”, and “Has difficulty awaiting turn”. High scores on an 
3Scientific RepoRts |          (2019) 9:9519  | https://doi.org/10.1038/s41598-019-45920-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
item thus indicated high level of problems in that area. Mean scores of the 9 items in each of the two dimensions 
were calculated.
Covariates. In gestational week 17, women were asked about their psychological and psychiatric problems 
prior to pregnancy (anxiety, depression, or eating disorders), height and pre-pregnancy weight, educational 
level, and smoking. Three years after delivery, women completed a short version of the Adult ADHD Self-Report 
Scale30, including four items on inattention and two items on impulsivity/hyperactivity from DSM-IV criteria 
of ADHD. Examples are: “When you have a task that requires a lot of thought, how often do you avoid or delay 
getting started?” and “How often do you fidget or squirm with your hands or feet when you have to sit down for 
a long time?” The items were rated on a five-point scale ranging from “never” to “very often”. A mean score was 
computed from these six items. This short scale is a good predictor of clinically assessed ADHD30, and has been 
used to adjust for maternal ADHD in previous studies of prenatal exposures and child outcomes21,25. The Medical 
Birth Registry of Norway provided information about parity, maternal age, and the child’s year of birth.
Potential multicollinearity between covariates can be expressed as their tolerance (i.e. the proportion of vari-
ance in each covariate independent of other covariates)31. Tolerance below 0.10 is often considered problematic31. 
All covariates had tolerance above 0.75.
Figure 1. Flow chart of numbers of participants in the analyses.
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Statistical analyses. The association between fever at any time during pregnancy and a registry-based 
ADHD diagnosis was examined in 99,947 children using logistic regression, because of the dichotomous nature 
of the outcome (ADHD diagnosis in NPR - yes/no). Associations between maternal fever episodes in different 
trimesters and child ADHD were also examined with logistic regression. Odds ratios (OR) and associated 95% 
confidence intervals (CI) were calculated. ORs are interpretable as the odds for the outcome among exposed chil-
dren divided by the odds among unexposed children. For relatively infrequent outcomes (i.e. 10% or less), OR is 
very similar to relative risk (RR)32.
Maternal fever and mother-reported ADHD symptoms at 8 years were examined in linear regression mod-
els. Mean scores of the nine inattention symptoms and the nine hyperactivity/impulsivity symptoms were 
log-transformed due to non-normality, standardized and used as outcomes in separate models. Results were 
interpretable in terms of units of standard deviation differences in the outcome between exposed and unexposed 
children (i.e. Cohen’s d).
Then, children of women taking versus not taking acetaminophen for their fever were allocated to differ-
ent groups, and compared to children of mothers unexposed to fever. This was done with logistic regression 
for ADHD diagnosis and with linear regression for the mother-reported symptoms, adjusting for covariates as 
described above. Three dummy-coded variables - no fever, fever without acetaminophen, and fever with acetami-
nophen - were constructed. The latter two were used as predictors, and the first (no fever) as reference category.
Based on previous literature15,21,25, we adjusted for the following potential confounders: maternal parity, his-
tory of psychological or psychiatric problems, age and educational level, pre-pregnancy BMI, smoking, and the 
child’s birth year. A confounder creates a spurious association between two variables by affecting both of them33. 
We therefore only used variables related to both exposure and outcome as potential confounders. Maternal alco-
hol consumption during pregnancy and child’s sex were considered, but omitted as covariates as they were not 
related to fever in pregnancy. Analyses also failed to show a clear sex difference in the association between fever 
in pregnancy and child ADHD diagnosis or symptoms. Boys and girls were therefore analysed together. Maternal 
ADHD symptoms were included as a covariate in the model even if it was measured three years after the child 
was born. This was done because of the importance of maternal ADHD as a potential cofounder of associations 
between prenatal exposures and child ADHD.
Analyses were performed in Mplus version 834. The Full Information Maximum Likelihood estimator was 
used, which allows using all data from participants with missing information.
Sensitivity analyses: Some children may have received an ADHD diagnosis before 2008 – the first year of 
person identifiable diagnoses in the NPR. They would not be registered in the NPR if they only had contact with 
primary care from 2008. To examine potential bias because of this, the association between maternal fever any-
time during pregnancy and child ADHD diagnosis was examined with logistic regression, adjusted for the same 
covariates as above, excluding children born before 2003.
Third-trimester fever was measured in the second and third questionnaires, without information about tem-
perature in the latter. Hence, women with temperatures below 38.5 degrees Celsius may have been included in 
the fever category in the third trimester, possibly attenuating the association between third-trimester fever and 
ADHD. To examine this, logistic regression analyses were performed excluding women reporting third-trimester 
fever only in the third questionnaire. ADHD diagnosis was included as outcome, with fever and the same covar-
iates as above as predictors.
Results
By the end of the follow-up period (December 2016), 2,941 children (3.0%) had an ADHD diagnosis registered 
in the NPR. Of those, 92.6% had at least two registrations. At that time, the mean age of the children was 11 years 
(range 7 to 17).
Characteristics of study participants are presented in Table 1. Using the ADHD Rating Scale, children with an 
ADHD diagnosis scored on average 2.2 standard deviations higher than children without a registry diagnosis on 
symptoms of inattention and hyperactivity/impulsivity at age 8 years (p < 0.01).
A total of 9,100 children were exposed to maternal fever during pregnancy (9.1%). Frequencies of fever and 
acetaminophen use in different trimesters are presented in the last two columns in Table 2.
The adjusted OR between fever at any time during pregnancy and offspring ADHD diagnosis was 1.30 (CI = 1. 
15–1. 47) (Table 2). First-trimester fever was associated with offspring ADHD after adjusting for covariates and 
fever in the other trimesters (OR = 1.31, CI = 1.06–1.61). The OR was 2.64 (CI = 1.36–5.14) for 178 children 
exposed to fever twice or more in the first trimester (see Fig. 2).
Fever at any time in pregnancy was associated with inattention symptoms reported in the 8-year questionnaire 
(Table 2). The adjusted associations were positive and statistically significant for fever in the first and second tri-
mesters, but this was not seen for fever in the third trimester.
Children of 1,631 mothers exposed to fever twice or more during the two first trimesters had the highest inat-
tention scores (Cohen’s d = 0.14, CI = 0.06–0.22). I.e., exposed children scored 0.14 standard deviations higher 
than unexposed children (see Fig. 3).
Maternal fever at any time during pregnancy was not associated with child hyperactivity/impulsivity symp-
toms at age 8 after adjusting for covariates. (Table 2).
Children of mothers with fever had similar odds of receiving an ADHD diagnosis whether or not the mother 
had taken acetaminophen (OR = 1.35, CI = 0.96–1.90 with acetaminophen, and OR = 1.32, CI = 1.01–1.71 with-
out acetaminophen) (see Fig. 4). Children of women who had taken acetaminophen for their fever in the first or 
second trimester, had similar inattention scores as children of mothers who had not taken acetaminophen for 
their fever. First trimester fever with acetaminophen: Cohen’s d = 0.08, CI = −0.02–0.18; without acetaminophen: 
Cohen’s d = 0.10, CI = 0.02–0.18. Fever in second trimester with acetaminophen: Cohen’s d = 0.04, CI = −0.02–
0.10; without acetaminophen: Cohen’s d = 0.06, CI = −0.02–0.14, (See Fig. 5).
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Sensitivity analyses. The adjusted association between maternal fever anytime during pregnancy and child 
ADHD diagnosis was OR = 1.33 (p < 0.001) when excluding children born before 2003.
Excluding women reporting third-trimester fever only in the third questionnaire (without temperature infor-
mation), did not increase the association between third-trimester fever and ADHD (OR = 0.80, p > 0.05).
Total sample1 
N = 99,947
Mother did not have fever during 
pregnancy N = 74,572
Mother had fever during 
pregnancy N = 9,100
Mean (SD) or N(%) Mean (SD) or N(%) Mean (SD) or N(%)
Maternal age at delivery
24 years or younger 11,175 (11.2%) 7,559 (10.1%) 1,090 (12.0%) **
25–34 years 71,372 (71.4%) 53,961 (72.4%) 6,497 (71.4%)
35 years or older 17,400 (17.4%) 13,052 (17.5%) 1,513 (16.6%)
Maternal education
University/college 60,693(60.7%) 46,842 (62.8%) 5,576 (61.3%) **
High school 26,441 (26.5%) 19,245 (25.8%) 2,382 (26.2%) **
Less than high school 7,658 (7.7%) 4,817 (6.5%) 692 (7.6%)
Missing information 5,155 (5.2%) 3,668 (4.9%) 450 (4.9%)
Maternal mental health problems before pregnancy 9,786 (9.8%) 6,820 (9.1%) 1,101 (12.1%)**
Maternal ADHD symptoms 1.09 (0.58) 1.08 (0.57) 1.14 (0.60)**
Maternal BMI2 24.0 (4.3) 24.0 (4.2) 24.4 (4.7)**
Maternal smoking 8,334 (8.5%) 5,463 (7.4%) 839 (9.4%)**
Parity = 0 44,770 (44.8%) 34,958 (46.9%) 3,232 (35.5%)**
Child’s sex = boy 51,151 (51.2%) 38,199 (51.2%) 4,604 (50.6%)





Child registered with ADHD diagnosis 2,941 (3.0%) 2,052 (2.8%) 350 (3.9%) **
ADHD symptoms (inattention) at 8 years3 1.55 (0.46) 1.55 (0.45) 1.58 (0.48)**
ADHD symptoms (hyper/imp) at 8 years3 1.39 (0.43) 1.39 (0.43) 1.41 (0.46)**
Table 1. Descriptive statistics by maternal fever status. Notes: 1All singletons in MoBa with information 
from the questionnaire in gestational week 17. 2BMI when mother became pregnant. 3ADHD symptoms are 
mean scores of nine items on inattention and nine items on hyperactivity/impulsivity, respectively, rated by 
mother from 1 (“Never/rarely”) to 4 (“very often”). The number of children with information in the 8-year 
questionnaire was 41,543. **Difference between mothers with versus without fever in pregnancy is statistically 
significant at p < 0.01.
ADHD diagnosis1 OR Inattention symptoms2 Cohen’s d
Hyperactivity/impulsivity 
symptoms2 Cohen’s d Number of 
mothers with 
fever




























































Table 2. Associations between fever in the different trimesters and offspring ADHD diagnoses and symptoms 
of inattention and hyperactivity/impulsivity. Notes: ***p < 0.001, **p < 0 0.01, *p < 0.05. 1Analyses of fever 
at any time during pregnancy included all children with information from the questionnaire in gestational 
week 17 (n = 99,947). Analyses of fever in the different trimesters included children with information from 
questionnaires in gestational weeks 17 and 30, as well as 6 months after birth (n = 82,264). 2Analyses of fever at 
any time during pregnancy included children born before 2009 with information from the first questionnaire 
(n = 96,794). Analyses of fever in the different trimesters included children born before 2009 with information 
from questionnaires completed in gestational weeks 17 and 30, as well as 6 months after birth (n = 79,773). The 
Full Information Maximum Likelihood estimator was used. Hence, participants who had not returned follow-up 
questionnaires were also included in the analyses. 3Unadjusted estimates: adjusted for child’s birth year, and fever 
in different trimesters are adjusted for each other. 4Analyses were adjusted for the following covariates: maternal 
age, maternal educational level, parity, maternal pre-pregnancy BMI, maternal pre-pregnancy psychological and 
psychiatric problems, maternal ADHD symptoms, maternal smoking, and child’s birth year.
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Discussion
Children exposed to maternal fever during pregnancy had increased risk of receiving an ADHD diagnosis and of 
elevated inattention symptoms at age 8 years. Increased risk of ADHD diagnosis was primarily associated with 
first-trimester fever. Inattention symptoms were associated with fever in the first, and, to some extent, the second 
trimester. There was no association between fever and hyperactivity/impulsivity after adjusting for covariates.
Most research on maternal fever during pregnancy has focused on congenital malformations (e.g., neural 
tube defects, congenital heart defects, oral clefts7). Associations with autism, cerebral palsy, developmental delay, 
decreased academic performance, psychosis, lack of task persistence and negative emotionality have also been 
shown3,6–8. Our results extend these observations by demonstrating an increased risk of ADHD diagnosis.
One previous study of prenatal fever and ADHD diagnosis found the association to be restricted to fever in 
gestational weeks 9 to 1215. Our results provide support for the highest risk being associated with exposure in 
early pregnancy, but the findings also suggest that inattention is associated with fever in a wider time period. The 
current study showed for the first time that repeated fever episodes in the beginning of pregnancy were associated 
with increased risk for both ADHD diagnosis and inattention symptoms. Children exposed twice or more, had 
Figure 2. Percentage of children with an ADHD diagnosis by number of maternal fever episodes in the first 
trimester. Notes: */**Differs from unexposed group at p < 0.05/p < 0.01 in logistic regression analyses adjusted 
for maternal age, maternal educational level, parity, maternal pre-pregnancy BMI, maternal pre-pregnancy 
psychological and psychiatric problems, maternal smoking, maternal ADHD symptoms, and child’s birth year. 
N in analysis = 82,264.
Figure 3. Child inattention scores by number of maternal fever episodes in the first and second trimesters. 
Notes: The y-axis shows standardized inattention scores (mean of the entire sample = 0, standard deviation = 1). 
*/** Differs from unexposed group at p < 0.05/p < 0.01 in linear regression analyses adjusted for maternal 
age, maternal educational level, parity, maternal pre-pregnancy BMI, maternal pre-pregnancy psychological 
and psychiatric problems, maternal smoking, maternal ADHD symptoms, and child’s birth year. The Full 
Information Maximum Likelihood estimator was used, allowing inclusion of participants who had not returned 
the 8-year questionnaire. Those who were born before 2009 were not old enough to have received their 8-year 
questionnaire and were thus not included. N in analyses = 79,773.
Figure 4. Percentage of children with an ADHD diagnosis by maternal fever and acetaminophen use in first 
trimester. Note: N = 82,264.
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more than two and a half times higher odds of getting an ADHD diagnosis compared to unexposed children, and 
they had the highest inattention symptoms.
Timing of prenatal exposures may influence the risk, with different disorders potentially resulting from variation 
in exposure across pregnancy periods35. Such trimester differences could reflect influences on various phases of brain 
development. The brain starts developing early in the first trimester, with neuron production beginning in the last part 
of the first trimester36. During the second trimester, the majority of neurons will have migrated to their final locations3. 
A recent study from MoBa showed that second-trimester fever was particularly associated with risk of autism spectrum 
disorders among offspring6. Our results suggest that both ADHD diagnosis and symptoms of inattention may be linked 
to maternal fever in early pregnancy. However, timing effects require verification over multiple studies.
Several maternal infections and autoimmune diseases during pregnancy are associated with neurodevelop-
mental disorders in the offspring, suggesting that factors common to these conditions may contribute to the 
increased risk35,37. Fever has been proposed as such a common factor4,35, and our study adds to previous knowl-
edge by examining the association between maternal fever and child ADHD directly, taking timing and repeated 
exposures into account. Hyperthermia during pregnancy is linked to several adverse outcomes in offspring, 
including growth retardation and developmental defects in both animal models5,14 and humans5. Hence, elevated 
temperature alone may exert teratogenic effects on the fetus, and may have detrimental effects on central nervous 
system development5,35. If hyperthermia is the mechanism linking maternal fever to offspring ADHD, the current 
study’s focus on higher reported levels of fever may lead to more accurate results.
An alternative explanation of the association between fever and child ADHD is that fever is a marker of another 
underlying process, for instance specific infections or immune disturbances, that contribute to the increased risk 
for ADHD. Fever reflects levels of pro-inflammatory cytokines as well as other molecules38, thus, maternal cytokine 
levels may cross the placenta to affect fetal brain development via mechanisms other than hyperthermia35.
The overall effect sizes were small in the current study. They are comparable to associations between prenatal 
exposures and child outcomes from other prospective cohort studies, which typically provide weaker estimates than 
those reported from case-control studies7. One explanation for this may be decreased risk of differential recall bias 
when data are collected prospectively7,39. It has been proposed that multiple environmental factors are involved in 
the development of ADHD, each with small effects40,41. If this model is correct, for each individual environmental 
factor studied, we would not expect more than weak associations. This has been seen as a parallel to the thousands 
of genetic variants that together affect ADHD, each variant with extremely weak associations to the disorder2,40,41.
The current associations between fever (anytime in pregnancy or in the first trimester) and ADHD diagnosis 
are similar to associations between maternal fever in pregnancy and neurodevelopmental disorders or related 
problems, as reported in previous prospective cohort studies (e.g. hazard ratio (HR) = 1.4 for autism, HR = 1.5 
for cerebral palsy, relative risk (RR) = 1.1 for psychosis-like experiences, OR = 1.3 for academic problems, and 
OR = 1.3 for lack of task persistence7). The association we found between multiple fever episodes in the first tri-
mester and ADHD diagnosis was somewhat higher than these previously reported estimates, and lower than a 
reported association between maternal fever and schizophrenia (OR = 3.7)7.
Effect sizes in our study are in line with previously reported associations between several prenatal exposures 
and different child outcomes from prospective cohort studies, such as maternal fever and neural tube defects 
(OR = 1.8)7, maternal anorexia nervosa and child being small for gestational age (RR = 1.5)42, acetaminophen 
use and ADHD (RR = 1.3)43, maternal fever and birth defects (RR = 2.3)7, and smoking and low birth weight 
(OR = 1.9)44. Regarding mother-reported symptoms in our study, associations with fever were comparable to 
several previous studies of different prenatal exposures and continuous child outcomes (e.g. maternal alcohol use 
and child ADHD symptoms (Beta = 0.05)45, and maternal smoking during pregnancy and internalizing symp-
toms in children (Beta = 0.11 and 0.06 – interpretable as Cohen’s d in that study46)). The association between 
exposure to multiple fever episodes in the beginning of pregnancy and inattention symptoms in our study was 
Figure 5. Child inattention scores by maternal fever and acetaminophen use in first and second trimester. 
Notes: The y-axis shows standardized inattention scores (mean of the entire sample = 0, standard deviation = 1). 
Adjusted for maternal age, maternal educational level, parity, maternal pre-pregnancy BMI, maternal pre-
pregnancy psychological and psychiatric problems, maternal smoking, maternal ADHD symptoms, and child’s 
birth year. The Full Information Maximum Likelihood estimator was used, allowing inclusion of participants 
who had not returned the 8-year questionnaire. Those who were born before 2009 were not old enough to have 
received their 8-year questionnaire and were thus not included. N in analyses = 79,773.
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also similar to a previously reported association between binge alcohol exposure in pregnancy and child cogni-
tion reported in a meta-analysis (Cohen’s d = 0.13)47.
The implications of reported effect sizes such as ORs, RRs and HRs, depend on the absolute risk of the disor-
der and the exposure, as well as on the duration and severity of the disorder. Both maternal fever in pregnancy 
and ADHD in children are common phenomena7,48. Hence, even a weak association between maternal fever and 
child ADHD may be important at a population level. This is emphasized by ADHD’s low age of onset, endurance 
into adulthood, and the fact that the disorder is associated with several adverse outcomes (e.g. academic prob-
lems, substance misuse, incarcerations and mortality2). Nevertheless, the current results show that each individ-
ual child exposed to fever in pregnancy, will most likely not develop ADHD or inattention problems.
ADHD is highly heritable, and the observed association between maternal fever and child ADHD could be 
confounded by genetic factors. We adjusted for maternal ADHD symptoms in the current study, but the associa-
tion could still be influenced by unmeasured common genetic or environmental factors that increase risk for both 
ADHD and fever. The current study included fever episodes from several trimesters in the same model. Stable 
confounding factors such as maternal general health, reporting bias, socioeconomic status, or genetic risk might 
be expected to affect fever in all three trimesters, and are less likely as explanations for trimester-specific associa-
tions with child ADHD. However, we cannot rule out trimester-specific confounding.
Acetaminophen use in pregnancy has previously been shown to be associated with ADHD20,21. In a recent 
study from MoBa, long-term use of acetaminophen during pregnancy was associated with increased risk of off-
spring ADHD. However, short-term use was associated with reduced risk. These findings are concordant with 
those obtained in a study on autism risk in the MoBa where use of acetaminophen was associated with reduced 
risk in mothers with fever during pregnancy6. Our results showed that risk of ADHD diagnosis and level of 
inattention symptoms were similar whether the mother had taken acetaminophen for their fever or not. This 
suggests that the association between fever in pregnancy and child ADHD is not due to detrimental effects of 
acetaminophen use among women with fever. Further, the observation that use of acetaminophen is insufficient 
to mitigate the fever-associated risk is consistent with a model wherein a larger set of innate immune responses 
contribute to outcomes of ADHD and inattention. One way to dissect the contributions of the innate immune 
system using questionnaire data would be to examine the impact of Non-Steroidal Anti-Inflammatory Drugs 
(e.g. ibuprofen). However, numbers are small, as pregnant women are often advised against these drugs during 
pregnancy. Very few women in the current study had used antipyretic medication other than acetaminophen.
The current study has not identified microbial causes of fever and immune responses. Further studies should exam-
ine what prenatal infections and inflammatory responses may increase the risk of negative outcomes in the offspring6.
Strengths of the study include its large sample size and prospective data collections. However, several limita-
tions warrant consideration. Only about 40% of the invited women consented to participation, potentially reduc-
ing the generalizability of our findings. Women younger than 25 years, with low educational level and smokers 
were under-represented44. However, ADHD prevalence, psychosocial adversity and child global functioning were 
found to be similar in MoBa and in the general Norwegian population49. Also, associations between variables 
tend to be more robust against selective non-response than estimates of means and frequencies44,50.
Some participants responding to the first questionnaire did not return later questionnaires. An advantage of the 
current study was inclusion of registry-based diagnostic outcome for all children, independent of questionnaire 
responses. For trimester-specific analyzes, only women who had responded to all three fever-questionnaires were 
included, potentially introducing bias. However, reports on fever in the first questionnaire revealed only minimal 
differences between those who did and did not return the later questionnaires at gestational week 30 and 6 months 
after birth. Among the former, 3.1% reported fever, 0.2% had two or more episodes, and 1.2% used acetaminophen 
for their fever in the first trimester. Among the latter, the corresponding numbers were 3.3%, 0.2%, and 1.1%. In 
addition, a Danish study found small effects of non-response at follow-up in a similar birth cohort51.
A strength in the current study is the repeated measures of fever during pregnancy. Nevertheless, self-reported 
fever may have low reliability and thus attenuate association estimates. Some studies may indicate that false neg-
atives are more common than false positives regarding self-reported fever52,53, meaning that under-reporting 
may be the biggest problem. Because the group of women without fever is very large in the current study, some 
false negatives is unlikely to affect results heavily. We were not able to detect multiple fever episodes within each 
four-week period in the first trimester. Hence, some women actually experiencing multiple fever episodes (e.g. 
two episodes in gestational weeks 0–4), may have been coded as having had only one fever episode. These women 
did thus not contribute to the estimate of associations between multiple fever episodes and child outcomes.
Self-reported fever may also be subject to systematic biases, if over- or underestimation of temperature is related 
to variables associated with child ADHD. For example, the current associations may be inflated or deflated if women 
with ADHD for some reason systematically over- or under-report fever more often than women without ADHD.
The proportion of women reporting fever during pregnancy in the current study was lower than in the Danish 
birth cohort15 and The National Birth Defects Prevention study54. This may be due to under-reporting of fever in 
the current study, or due to our definition of fever as temperature above 38.5 degrees Celsius. In the Danish birth 
cohort, most of the fever cases were classified as low intensity (low temperature and/or short duration).
Information about acetaminophen use was only a yes/no variable for each fever period, without information 
about duration or dosage. We cannot rule out that results would have been different with more detailed informa-
tion about this.
We did not have information about women’s substance use or psychotic episodes before or during pregnancy. 
This may have biased results.
Some children may have undiagnosed ADHD. This may be particularly relevant for the youngest children, as 
ADHD prevalence within the NPR increases from age 5 to age 1155. At end of follow-up, only 3.2% of the children 
in our sample were 7 years old, and half of the children were 11 years old or more. Age differences in the likeli-
hood of having received a diagnosis was accounted for by adjusting analyses for child’s birth year.
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Conclusion
The results indicate that maternal fever in early pregnancy may be a risk factor for ADHD, and particularly for 
inattention problems. Children exposed twice or more in the first trimester, had more than doubled odds of 
receiving an ADHD diagnosis compared to unexposed children. This risk was neither mitigated nor increased by 
use of acetaminophen.
Strategies that minimize the risk of maternal infection, the most common cause of fever, may contribute to 
reducing ADHD and inattention problems in children. Future studies should investigate the mechanisms by 
which maternal fever might create risk for adverse neurodevelopmental outcomes such as ADHD, as well as 
scrutinize the efficacy of different antipyretics in mitigating such risk.
Data Availability
Data from the Norwegian Mother and Child Cohort Study and registers used in this study are managed by the 
national health register holders in Norway and can be made available to researchers, provided necessary approval 
from the Regional Ethics Committee in Norway and from the data owners. The Norwegian Institute of Public 
Health has a general contact point for data access at the mail-address: datatilgang@fhi.no.
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